Literature DB >> 33374102

Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines.

Sára Kellnerová1, Sneha Chatterjee1, Rafael Bayarri-Olmos2, Louise Justesen2, Heribert Talasz3, Wilfried Posch1, Samyr Kenno1, Peter Garred2, Dorothea Orth-Höller1, Marco Grasse1, Reinhard Würzner1.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) infections can cause EHEC-associated hemolytic uremic syndrome (eHUS) via its main virulent factor, Shiga toxins (Stxs). Complement has been reported to be involved in the progression of eHUS. The aim of this study was to investigate the interactions of the most effective subtype of the toxin, Stx2a, with pivotal complement proteins C3b and C5. The study further examined the effect of Stx2a stimulation on the transcription and synthesis of these complement proteins in human target cell lines. Binding of Stx2a to C3b and C5 was evaluated by ELISA. Kidney and gut cell lines (HK-2 and HCT-8) were stimulated with varied concentrations of Stx2a. Subsequent evaluation of complement gene transcription was studied by real-time PCR (qPCR), and ELISAs and Western blots were performed to examine protein synthesis of C3 and C5 in supernatants and lysates of stimulated HK-2 cells. Stx2a showed a specific binding to C3b and C5. Gene transcription of C3 and C5 was upregulated with increasing concentrations of Stx2a in both cell lines, but protein synthesis was not. This study demonstrates the binding of Stx2a to complement proteins C3b and C5, which could potentially be involved in regulating complement during eHUS infection, supporting further investigations into elucidating the role of complement in eHUS pathogenesis.

Entities:  

Keywords:  C3; C5; HCT-8; HK-2; Shiga toxin 2a; hemolytic uremic syndrome; intracellular complement

Mesh:

Substances:

Year:  2020        PMID: 33374102      PMCID: PMC7824702          DOI: 10.3390/toxins13010008

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   5.075


  50 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease?

Authors:  Annika Sünderhauf; Kerstin Skibbe; Sophie Preisker; Karen Ebbert; Admar Verschoor; Christian M Karsten; Claudia Kemper; Markus Huber-Lang; Marijana Basic; André Bleich; Jürgen Büning; Klaus Fellermann; Christian Sina; Stefanie Derer
Journal:  Mol Immunol       Date:  2017-08-24       Impact factor: 4.407

3.  Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.

Authors:  Anne-lie Ståhl; Lisa Sartz; Diana Karpman
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

4.  Local synthesis of complement component C3 regulates acute renal transplant rejection.

Authors:  Julian R Pratt; Shamim A Basheer; Steven H Sacks
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

5.  Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.

Authors:  J Passwell; G F Schreiner; M Nonaka; H U Beuscher; H R Colten
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

6.  Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.

Authors:  Marina Noris; Miriam Galbusera; Sara Gastoldi; Paolo Macor; Federica Banterla; Elena Bresin; Claudio Tripodo; Serena Bettoni; Roberta Donadelli; Elisabetta Valoti; Francesco Tedesco; Alessandro Amore; Rosanna Coppo; Piero Ruggenenti; Eliana Gotti; Giuseppe Remuzzi
Journal:  Blood       Date:  2014-07-18       Impact factor: 22.113

7.  Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis.

Authors:  Min Chen; Guang-Qun Xing; Feng Yu; Gang Liu; Ming-Hui Zhao
Journal:  Nephrol Dial Transplant       Date:  2008-10-21       Impact factor: 5.992

8.  Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories.

Authors:  Thomas G Berger; Bernadette Feuerstein; Erwin Strasser; Ute Hirsch; Doris Schreiner; Gerold Schuler; Beatrice Schuler-Thurner
Journal:  J Immunol Methods       Date:  2002-10-15       Impact factor: 2.303

9.  Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.

Authors:  Dorothea Orth; Abdul Basit Khan; Asma Naim; Katharina Grif; Jens Brockmeyer; Helge Karch; Michael Joannidis; Simon J Clark; Anthony J Day; Sonja Fidanzi; Heribert Stoiber; Manfred P Dierich; Lothar B Zimmerhackl; Reinhard Würzner
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  Calculation of the ELISA's cut-off based on the change-point analysis method for detection of Trypanosoma cruzi infection in Bolivian dogs in the absence of controls.

Authors:  Frédéric Lardeux; Gino Torrico; Claudia Aliaga
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-07-04       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.